Cart
sales@molnova.com
Stafia-1
CAS No. 2582757-90-0
Stafia-1 ( —— )
Catalog No. M28612 CAS No. 2582757-90-0
Stafia-1 is a potent STAT5a inhibitor ( IC50=22.2 μM). Stafia-1 displays high selectivity over STAT5b and other STAT family members.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | Get Quote |
|
| 10MG | 293 | Get Quote |
|
| 25MG | 498 | Get Quote |
|
| 50MG | 716 | Get Quote |
|
| 100MG | 981 | Get Quote |
|
| 500MG | 1998 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameStafia-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionStafia-1 is a potent STAT5a inhibitor ( IC50=22.2 μM). Stafia-1 displays high selectivity over STAT5b and other STAT family members.
-
DescriptionStafia-1 is a potent STAT5a inhibitor ( IC50=22.2 μM). Stafia-1 displays high selectivity over STAT5b and other STAT family members.
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorNOP receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2582757-90-0
-
Formula Weight506.4
-
Molecular FormulaC24H27O10P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=CC(C2=CC(OP(O)(O)=O)=CC(C3=CC(OC)=C(OC)C(OC)=C3)=C2)=CC(OC)=C1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Thomsen C, Hohlweg R. (8-Naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4. 5]dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist. Br J Pharmacol. 2000 Nov;131(5):903-8.
molnova catalog
related products
-
ML115
ML115 is a potent and selective activator of transcription 3 (STAT3), with abn EC50 of 2.0 nM, and is inactive against the related STAT1 and NFκB anti-targets.
-
Guanosine
Guanosine is a purine nucleoside formed from a beta-N9-glycosidic bond between guanine and a ribose ring and is essential for metabolism.
-
Colivelin
Colivelin is a neuroprotective peptide and activator of STAT3. Colivelin is a hybrid peptide synthesized to enhance the neuroprotective effects of humanin (HN).
